Tech Company Financing Transactions
Cure51 Funding Round
Cure51 secured a $16.3 million Seed funding round on 3/20/2024. Backers included Sofinnova Partners, Hitachi Ventures and private investors.
Transaction Overview
Company Name
Announced On
3/20/2024
Transaction Type
Venture Equity
Amount
$16,280,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to expand its development efforts.
Company Information
Company Status
Private & Independent
Industry
Software
Mailing Address
26 Rue des Renaudes
Paris, 75017
France
Paris, 75017
France
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
At Cure51 our mission is to create the first worldwide database of cancer survivors to leverage their exceptional biological features and find new drugs to cure Cancer. Cure51 gathers talents coming from various areas of expertise -- from biocomputation, to data engineering, biological samples analysis or Tech infrastructure -- all driven by the same passion : cure cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nicolas Wolikow
Chief Financial Officer
David Ouaknine
Chief Operating Officer
El Mehdi Ouzgane
Chief Technical Officer
Eric Delaloy
VP - Administration
Emna Makhlouf
VP - Bus. Development
Simon Istolainen
Browse more venture capital transactions:
Prev: 3/20/2024: Monaire venture capital transaction
Next: 3/20/2024: StepsConnect venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs